 |
 |
 |
|
Fosamprenavir/Ritonavir (FPV/r) in Hepatically Impaired Subjects: An Observational Multi-Cohort Study
|
|
|
Reported by Jules Levin
ICAAC 2013 Sept 10-13 Denver, CO
P Nasta,1 D Salmon,2 A D'Arminio Monforte,3 J Pimenta,4 C Cerini,1 E Chiari,1 M Winnock,5 A Cozzi-Lepri6
1Spedali Civili Hospital, Brescia, Italy; 2Universite Paris Descartes, Paris, France; 3San Paolo Hospital, Milan, Italy; 4GlaxoSmithKline, Stockley Park, UK; 5Universite Victor Segalen, Bordeaux, France; 6University College London, London, UK





|
|
|
 |
 |
|
|